TGFB1 and neoplasm: These data further support the notion that a hyperactive TGF-β/Smad3 pathway suppresses miR-29c expression, resulting in Wnt signaling activation and the consequent promotion of malignant PANC phenotypes, high tumor recurrence rate and poor prognosis of clinical PANC.